Following are
the correct answers in relation to type 4
hypersensitivity.
- Type 4 hypersensitivity is
also referred to as delayed hypersensitivity :
It takes 2 to 3 days for the reaction to develop after
exposure to the particular substance, so it is referred to as
delayed hypersensitivity
- Type 4 hypersensitivity is
mediated by T-cells and the effector cells that they
recruit : Type IV hypersensitivity is characterized by
cell-mediated response rather than antibodies as in other types of
hypersensitivity reactions. Specifically, the T lymphocytes are
involved in the development of the sensitivity, hence called
cell-mediated hypersensitivity. T lymphocytes are white blood cells
in the body. After exposure to antigens, through a series of
biochemical events, the T-cells will be activated. the T
cells activate other white blood cells to mount an immune
response.It involves activated T cells, which release cytokines and
chemokines, and macrophages and cytotoxic CD8+ T cells
that are attracted by these moietis.
- Type 4 hypersensitivity is
most appropriately treated with antihistamines :
Antihistamines suppress the histamine-induced wheal response
(swelling) and flare response (vasodilation) by blocking the
binding of histamine to its receptors or reducing histamine
receptor activity on nerves, vascular smooth muscle, glandular
cells, endothelium, and mast cells.
Answers that are not correct
in understanding type 4 hypersensityvity.
- The severity of the
reaction depends upon whether IgG, IgM, or IgE are
involved : Type IV hypersensityvity reaction is
not antibody-mediated but rather is a type of
cell-mediated response. This response involves the interaction of
T-cells, monocytes, and macrophages. Ig E involved in type I,Ig G
invoved in type II and type III and the Ig G involved in type II
also.
- Type 4 hypersensitivity may
result from mismatched blood transfusions: Type II
hypersensitive reactions involve antibody-mediated
destruction of cells. This type of
reaction is best seen by
blood-transfusion reactions, in
which host antibodies react with foreign antigens
on the incompatible transfused blood cells and
mediate destruction of these cells.